Arild Nesbakken - Concepedia

Author

Arild Nesbakken

Oslo University Hospital

Also Known As

A Nesbakken, A. Nesbakken, A.N. Nesbakken, Arild Nesbakken, Domenico Soriero, I Negoi, Morten H Vatn, Nesbakken, Arild

186

Publications

10.9K

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital University of Oslo Akershus University Hospital University of Bergen Norwegian Cancer Society

About

Arild Nesbakken is an author at Oslo University Hospital specializing in medicine, colorectal cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	31	4.5K
2	Engineering	3	3	641
3	Health Sciences	3	3	170
4	Biostatistics	3	3	658
5	Public Health	2	2	64

Arild Nesbakken

Publications

9.9K

Citations

H-Index

Page 1

	Year	Citations
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, The Lancet Oncology Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicineColorectal Cancer	2020	1.5K
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study Ole-Johan Skrede, Sepp de Raedt, Andreas Kleppe, The Lancet Colorectal Cancer OutcomeConvolutional Neural NetworkEngineeringMachine LearningData Science	2020	594
Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: A prospective observational cohort study Arild Nesbakken, Eva Skovlund, Riccardo A. Audisio, Critical Reviews in Oncology/Hematology Geriatric OncologyOncologyAgingSurgical OncologyGeriatrics	2009	446
Outcome and late functional results after anastomotic leakage following mesorectal excision for rectal cancer Arild Nesbakken, K. Nygaard, O. C. Lunde British journal of surgery	2001	364
Bladder and sexual dysfunction after mesorectal excision for rectal cancer Arild Nesbakken, K. Nygaard, T Bull-Njaa, British journal of surgery	2000	284
Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer Rodrigo Dienstmann, Guillermo Villacampa, Anita Sveen, Annals of Oncology	2019	259
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study Rodrigo Dienstmann, Mike J. Mason, Frank A. Sinicrope, Annals of Oncology	2017	245
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies Anita Sveen, Jarle Bruun, Peter W. Eide, Clinical Cancer Research	2017	245
Short term outcome after emergency and elective surgery for colon cancer O. Sjö, Stein Gunnar Larsen, O. C. Lunde, Colorectal Disease	2008	241
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery Karl Søndenaa, Philip Quirke, Werner Hohenberger, International Journal of Colorectal Disease Surgical OncologyColorectal SurgeryMedicineGastroenterologyVascular Surgery	2014	220

Page 1